Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03269630 · ClinicalTrials.gov registry record
New Orleans Pulmonary Hypertension Biobank
A clinical trial of Healthy and Pulmonary Hypertension, sponsored by Louisiana State University Health Sciences Center in New Orleans.
- Recruiting
- Registry status
- 450
- Enrollment target
- 1
- Study location
NCT03269630 is a study of Healthy and Pulmonary Hypertension that is actively recruiting participants, run by Louisiana State University Health Sciences Center in New Orleans. The registered enrollment target is 450 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03269630, a study of Healthy and Pulmonary Hypertension, is actively recruiting participants, sponsored by Louisiana State University Health Sciences Center in New Orleans.
- RECRUITING
- Registry status
- 450 participants
- Enrollment target
- 1
- Study location
Study Summary
Pulmonary hypertension (PH) is a serious condition characterized by a mean pulmonary artery pressure \>=25mmHg on right heart catheterization (RHC). Despite advances in PH care, outcomes are still sub-optimal and further research is required into the pathobiology of the disease and development of biomarkers that can guide clinical care. The investigators are establishing a biobank to collect samples (blood, urine, stool) from patients with pulmonary hypertension, patients at high risk for pulmonary hypertension, healthy controls, and patients undergoing right heart catheterization. Specimens will be stored for future investigations.
Conditions Studied
Interventions
- OTHER No intervention. Biospecimen collection only
Study Locations (1)
Louisiana
- University Medical Center-New Orleans - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2017-12-29 |
| Est. Completion | 2027-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03269630
The ClinicalTrials.gov registry entry for NCT03269630 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (30% lower). The listed sponsor is Louisiana State University Health Sciences Center in New Orleans, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which No intervention. Biospecimen collection only is the first listed.
NCT03269630 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT03269630 about?
NCT03269630 is a clinical study titled "New Orleans Pulmonary Hypertension Biobank". Pulmonary hypertension (PH) is a serious condition characterized by a mean pulmonary artery pressure \>=25mmHg on right heart catheterization (RHC). Despite advances in PH care, outcomes are still sub-optimal and further research is required into the pathobiology of the disease and development of bi...
What is the current status of trial NCT03269630?
This trial is currently recruiting. The enrollment target is 450 participants. The study started on 2017-12-29. Estimated completion is 2027-10.
What conditions does trial NCT03269630 study?
This clinical trial studies the following conditions: Healthy, Pulmonary Hypertension, Systemic Sclerosis, Heart Failure With Normal Ejection Fraction, Mixed Connective Tissue Disease.
What interventions are being tested in trial NCT03269630?
The interventions under investigation include: No intervention. Biospecimen collection only (OTHER).
Who is sponsoring clinical trial NCT03269630?
This trial is sponsored by Louisiana State University Health Sciences Center in New Orleans, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03269630 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.